Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas

[1]  Yu‐Min Lin,et al.  Hepatocyte Growth Factor Increases Vascular Endothelial Growth Factor-A Production in Human Synovial Fibroblasts through c-Met Receptor Pathway , 2012, PloS one.

[2]  C. Koumenis,et al.  Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia , 2012, Cancer biology & therapy.

[3]  D. Ribatti,et al.  Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets , 2012, Oncogene.

[4]  W. Zhang,et al.  Targeting 14-3-3zeta in cancer therapy , 2011, Cancer Gene Therapy.

[5]  M. Imoto,et al.  Involvement of 14-3-3 Proteins in the Second Epidermal Growth Factor-induced Wave of Rac1 Activation in the Process of Cell Migration* , 2011, The Journal of Biological Chemistry.

[6]  Dihua Yu,et al.  Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit , 2011, Oncogene.

[7]  Hong Lin,et al.  14-3-3Zeta Positive Expression is Associated With a Poor Prognosis in Patients With Glioblastoma , 2011, Neurosurgery.

[8]  A. Matsumura,et al.  Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image , 2011, Journal of Neuro-Oncology.

[9]  Z. Fei,et al.  Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice , 2010, Apoptosis.

[10]  A. Argyriou,et al.  Angiogenesis and Anti-Angiogenic Molecularly Targeted Therapies in Malignant Gliomas , 2009, Oncology.

[11]  R. Jensen,et al.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target , 2009, Journal of Neuro-Oncology.

[12]  Hong Lin,et al.  Isoform-specific expression of 14-3-3 proteins in human astrocytoma , 2009, Journal of the Neurological Sciences.

[13]  Hong Lin,et al.  Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry , 2008, Neuroscience Letters.

[14]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[15]  D. Gillespie,et al.  Silencing of Hypoxia Inducible Factor-1α by RNA Interference Attenuates Human Glioma Cell Growth In vivo , 2007, Clinical Cancer Research.

[16]  M. Slomiany,et al.  Hypoxia-Inducible Factor-1-Dependent and -Independent Regulation of Insulin-Like Growth Factor-1-Stimulated Vascular Endothelial Growth Factor Secretion , 2006, Journal of Pharmacology and Experimental Therapeutics.

[17]  A. Aitken.  14-3-3 proteins: a historic overview. , 2006, Seminars in cancer biology.

[18]  H. Zhen,et al.  Immunocytochemical detection of 14-3-3 in primary nervous system tumors , 2006, Journal of Neuro-Oncology.

[19]  David N Louis,et al.  Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.

[20]  D. Zagzag,et al.  Angiogenesis in Gliomas: Biology and Molecular Pathophysiology , 2005, Brain pathology.

[21]  Fuminori Tsuruta,et al.  JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3 , 2005, The Journal of cell biology.

[22]  Daniel J Brat,et al.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. , 2005, Neuro-oncology.

[23]  P. Kleihues,et al.  Epidemiology and etiology of gliomas , 2005, Acta Neuropathologica.

[24]  M. Oksvold,et al.  Identification of 14‐3‐3ζ as an EGF receptor interacting protein , 2004, FEBS letters.

[25]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.

[26]  Daniel J Brat,et al.  Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population , 2004, Cancer Research.

[27]  K. Plate,et al.  VEGF in Brain Tumors , 2000, Journal of Neuro-Oncology.

[28]  Jinfeng Li,et al.  [WHO classification of tumors of the breast]. , 2014, Zhonghua wai ke za zhi [Chinese journal of surgery].

[29]  M. Campone,et al.  Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. , 2009, Current molecular pharmacology.

[30]  W. Remmele,et al.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer , 2004, Virchows Archiv A.

[31]  R. Tsang,et al.  Interrelationship of proliferation and hypoxia in carcinoma of the cervix. , 2000, International journal of radiation oncology, biology, physics.